-
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. J Clin Oncol. 2024 Mar 29; JCO2400033.
Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA. PMID: 38552193.
View in:
PubMed Mentions: Fields:
-
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience. Clin Lymphoma Myeloma Leuk. 2023 Dec; 23(12):874-881.
Galligan D, Williamson S, Myers J, Chen AI, Hayes-Lattin B, Okada C, Spurgeon S, Maziarz R, Schachter L. PMID: 37741763.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma. Leuk Lymphoma. 2023 Jul-Aug; 64(8):1472-1475.
Banerjee T, Newman M, Chen A, Maziarz RT, Schachter L, Spurgeon SE, Vallurupalli A. PMID: 37287113.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma. Transplant Cell Ther. 2023 07; 29(7):449.e1-449.e7.
Ahmed N, Wesson W, Mushtaq MU, Porter DL, Nasta SD, Brower J, Bachanova V, Hu M, Nastoupil LJ, Oluwole OO, Patel VG, Oliai C, Riedell PA, Bishop MR, Shah GL, Perales MA, Schachter L, Maziarz RT, McGuirk JP. PMID: 37120134.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas. Transplant Cell Ther. 2022 10; 28(10):669-676.
Riedell PA, Hwang WT, Nastoupil LJ, Pennisi M, McGuirk JP, Maziarz RT, Bachanova V, Oluwole OO, Brower J, Flores OA, Ahmed N, Schachter L, Bharucha K, Dholaria BR, Schuster SJ, Perales MA, Bishop MR, Porter DL. PMID: 35850429; PMCID: PMC9547952.
View in:
PubMed Mentions:
18 Fields:
Translation:
Humans
-
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL. Blood. 2022 06 30; 139(26):3722-3731.
Gauthier J, Gazeau N, Hirayama AV, Hill JA, Wu V, Cearley A, Perkins P, Kirk A, Shadman M, Chow VA, Gopal AK, Hodges Dwinal A, Williamson S, Myers J, Chen A, Nagle S, Hayes-Lattin B, Schachter L, Maloney DG, Turtle CJ, Sorror ML, Maziarz RT. PMID: 35439295; PMCID: PMC9247364.
View in:
PubMed Mentions:
20 Fields:
Translation:
HumansCells
-
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood. 2021 12 02; 138(22):2278-2289.
Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta R, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin J, Im A, Langston A, Liesveld J, Juckett M, Logan A, Schachter L, Alavi A, Howard D, Waksal HW, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green L, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic S. PMID: 34265047; PMCID: PMC8641099.
View in:
PubMed Mentions:
65 Fields:
Translation:
HumansCTClinical Trials
-
Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience. Clin Lymphoma Myeloma Leuk. 2022 02; 22(2):105-112.
Galligan D, Williamson S, Myers J, Silbermann R, Medvedova E, Nagle S, Schachter L, Chen A, Scott E, Maziarz R. PMID: 34686447.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies. Am J Hematol. 2021 04 01; 96(4):455-461.
Nagle SJ, Murphree C, Raess PW, Schachter L, Chen A, Hayes-Lattin B, Nemecek E, Maziarz RT. PMID: 33529419.
View in:
PubMed Mentions:
23 Fields:
Translation:
Humans
-
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes. Biol Blood Marrow Transplant. 2020 11; 26(11):2139-2146.
Nazha A, Hu ZH, Wang T, Lindsley RC, Abdel-Azim H, Aljurf M, Bacher U, Bashey A, Cahn JY, Cerny J, Copelan E, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla SM, Gale RP, George B, Gergis U, Grunwald MR, Hamilton B, Hashmi S, Hildebrandt GC, Inamoto Y, Kalaycio M, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Liesveld JL, Litzow MR, Majhail NS, Murthy HS, Nathan S, Nishihori T, Pawarode A, Rizzieri D, Sabloff M, Savani BN, Schachter L, Schouten HC, Seo S, Shah NN, Solh M, Valcárcel D, Vij R, Warlick E, Wirk B, Wood WA, Yared JA, Alyea E, Popat U, Sobecks RM, Scott BL, Nakamura R, Saber W. PMID: 32781289; PMCID: PMC7609542.
View in:
PubMed Mentions:
7 Fields:
Translation:
Humans
-
Working words: real-life lexicon of North American workers. J Occup Environ Med. 2005 Aug; 47(8):859-64.
Harber P, Crawford L, Liu K, Schachter L, Schacter L. PMID: 16093937.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Computational study of fluid mechanical disturbance induced by endovascular stents. Ann Biomed Eng. 2005 Apr; 33(4):444-56.
Seo T, Schachter LG, Barakat AI. PMID: 15909650.
View in:
PubMed Mentions:
28 Fields:
Translation:
HumansAnimals